Whole-genome screening in ankylosing spondylitis: Evidence of non-MHC genetic-susceptibility loci

Citation
Sh. Laval et al., Whole-genome screening in ankylosing spondylitis: Evidence of non-MHC genetic-susceptibility loci, AM J HU GEN, 68(4), 2001, pp. 918-926
Citations number
45
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
Journal title
AMERICAN JOURNAL OF HUMAN GENETICS
ISSN journal
00029297 → ACNP
Volume
68
Issue
4
Year of publication
2001
Pages
918 - 926
Database
ISI
SICI code
0002-9297(200104)68:4<918:WSIASE>2.0.ZU;2-S
Abstract
Ankylosing spondylitis (AS) is a common inflammatory arthritis predominantl y affecting the axial skeleton. Susceptibility to the disease is thought to be oligogenic. To identify the genes involved, we have performed a genomew ide scan in 185 families containing 255 affected sibling pairs. Two-point a nd multipoint nonparametric linkage analysis was performed. Regions were id entified showing "suggestive" or stronger linkage with the disease on chrom osomes 1p, 2q, 6p, 9q, 10q, 16q, and 19q. The MHC locus was identified as e ncoding the greatest component of susceptibility, with an overall LOD score of 15.6. The strongest non-MHC linkage lies on chromosome 16q (overall LOD score 4.7). These results strongly support the presence of non-MHC genetic -susceptibility factors in AS and point to their likely locations.